{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:23:14Z","timestamp":1789028594675,"version":"build-2803163510"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T00:00:00Z","timestamp":1680220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>The increased effectiveness of antiretroviral therapy (ART) in the last 30\u00a0years is a scientific landmark, and viral suppression is directly associated with treatment adherence. The aim of this study was to compare the results of ART adherence and viral load suppression with the evolution of the protocols and other associated factors, in people living with HIV. A panel analysis of three descriptive longitudinal studies investigating ART adherence and viral load suppression was conducted in people with HIV treated at a drug dispensing unit in the Federal District. The studies were carried out during periods of 2011, 2013, and 2017, coinciding with the three different recommended treatment schemes for the country. Adherence was assessed using drug dispensing records. Viral load data were obtained from the Ministry of Health\u02bcs Laboratory Examination Information System. Analysis of the data of 522 individuals in the three periods showed sociodemographic differences such as a decline in the percentage of women (from 33% in period 1 to 4% in period 3) and an increase in the percentage of young people. ART adherence was higher in period 2 (tenofovir\/lamivudine\/efavirenz scheme). Viral load suppression was greater in period 3 (tenofovir\/lamivudine\/dolutegravir scheme). The relative detectable viral load risk was nearly two-fold higher (RR 1.83) in people living with HIV with less than 80% adherence when compared to those above 80%. With respect to the different schemes recommended in Brazil during the periods studied, ART containing dolutegravir was the most effective in achieving viral load suppression. By contrast, there was better ART adherence in the daily combined fixed dose consisting of tenofovir\/lamivudine\/efavirenz in tablet form. Adherence to ART above 80% seemed to be enough to promote an effective treatment in therapeutic schemes including efavirenz or dolutegravir.<\/jats:p>","DOI":"10.3389\/fphar.2023.1122018","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T20:27:58Z","timestamp":1680294478000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Adherence to antiretroviral therapy and viral suppression: Analysis of three periods between 2011 and 2017 at an HIV-AIDS center, Brazil"],"prefix":"10.3389","volume":"14","author":[{"given":"Micheline Marie","family":"Milward de Azevedo Meiners","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Ara\u00fajo Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria In\u00eas","family":"de Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2147\/PPA.S192735","article-title":"Adherence to HIV treatment regimens: Systematic literature review and meta-analysis","volume":"13","author":"Altice","year":"2019","journal-title":"Patient Prefer Adherence"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e14828","DOI":"10.1097\/MD.0000000000014828","article-title":"The Brazilian experience of implementing the active pharmacovigilance of dolutegravir","volume":"98","author":"Batista","year":"2019","journal-title":"Med. Baltim."},{"key":"B3","first-page":"28","article-title":"An\u00e1lise da ades\u00e3o \u00e0 Terapia Antirretroviral de Pessoas que Vivem com HIV\/aids atendidas em uma unidade de dispensa\u00e7\u00e3o do Distrito Federal","volume-title":"Trabalho de conclus\u00e3o de curso em Farm\u00e1cia. Faculdade de Ci\u00eancias da Sa\u00fade","author":"Batista","year":"2018"},{"key":"B4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12981-019-0234-2","article-title":"Antiretroviral treatment, government policy and economy of HIV\/AIDS in Brazil: Is it time for HIV cure in the country?","volume":"16","author":"Benzaken","year":"2019","journal-title":"AIDS Res. Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e3361","DOI":"10.1097\/MD.0000000000003361","article-title":"Adherence to antiretroviral therapy and virologic failure: A meta-analysis","volume":"95","author":"Bezabhe","year":"2016","journal-title":"Med. Baltim."},{"key":"B6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40249-016-0179-9","article-title":"Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count","volume":"5","author":"Bigna","year":"2016","journal-title":"Infect. Dis. Poverty"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1371\/journal.pmed.0050109","article-title":"Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy","volume":"5","author":"Bisson","year":"2008","journal-title":"PLoS Med."},{"key":"B8","first-page":"23725","volume-title":"Lei no 9.313, de 13 de novembro de 1996","year":"1996"},{"key":"B9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11904-018-0377-0","article-title":"Adherence measurements in HIV: New advancements in pharmacologic methods and real-time monitoring","volume":"15","author":"Castillo-Mancilla","year":"2018","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.2147\/DDDT.S140767","article-title":"Two-drug regimens for treatment of na\u00efve HIV-1 infection and as maintenance therapy","volume":"12","author":"Corado","year":"2018","journal-title":"Drug Des. Devel Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.11606\/S1518-8787.2018052000399","article-title":"Effectiveness of antiretroviral therapy in the single-tablet regimen era","volume":"52","author":"Cecatto","year":"2018","journal-title":"Rev. Saude Publica"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0170661","DOI":"10.1371\/journal.pone.0170661","article-title":"Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - results from a large French multicenter cohort study","volume":"12","author":"Cotte","year":"2017","journal-title":"PLoS One"},{"key":"B13","first-page":"59","article-title":"Registro de dispensa\u00e7\u00e3o de medicamentos e resposta \u00e0 terapia antirretroviral","volume-title":"Disserta\u00e7\u00e3o de mestrado em Ci\u00eancias da Sa\u00fade. Faculdade de Ci\u00eancias da Sa\u00fade","author":"Cunha","year":"2014"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e00136216","DOI":"10.1590\/0102-311X00136216","article-title":"Use of pharmacy records to measure treatment adherence: A critical review of the literature","volume":"33","author":"da Costa Lima-Dellamora","year":"2017","journal-title":"Cad. Sa\u00fade P\u00fablica."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e218111335024","DOI":"10.33448\/rsd-v11i13.35024","article-title":"A import\u00e2ncia do profissional farmac\u00eautico na ades\u00e3o \u00e0 Terapia Antirretroviral (TARV) na gest\u00e3o do cuidado em HIV\/AIDS","volume":"11","author":"da Silva","year":"2022","journal-title":"Res. Soc. Dev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.18553\/jmcp.2018.17507","article-title":"Risk factors, health care resource utilization, and costs associated with nonadherence to antiretrovirals in medicaid-insured patients with HIV","volume":"24","author":"Dunn","year":"2018","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"B17","first-page":"48","article-title":"Uso de tenofovir e altera\u00e7\u00e3o da fun\u00e7\u00e3o renal","volume-title":"Trabalho de conclus\u00e3o de curso em Farm\u00e1cia. Faculdade de Ci\u00eancias da Sa\u00fade","author":"Fagundes","year":"2017"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e20180126","DOI":"10.1590\/0037-8682-0126-2018","article-title":"Clinical and epidemiology evaluation of aids-infected patients hospitalized between 2011 and 2016 in the Santos region of Brazil","volume":"52","author":"Focaccia","year":"2019","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5456219","DOI":"10.1155\/2017\/5456219","article-title":"Evaluating adherence to antiretroviral therapy using pharmacy refill records in a rural treatment site in south Africa","volume":"2017","author":"Gachara","year":"2017","journal-title":"AIDS Res. Treat."},{"key":"B20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/s0104-4230(12)70184-7","article-title":"Factors determining changes in initial antiretroviral therapy","volume":"55","author":"Lima","year":"2012","journal-title":"Rev. Assoc. Med. Bras."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1097\/QAD.0000000000002254","article-title":"Comparative effectiveness of first-line antiretroviral therapy: Results from a large real-world cohort after the implementation of dolutegravir","volume":"33","author":"Meireles","year":"2019","journal-title":"AIDS"},{"key":"B22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/s-0037-1613689","article-title":"Vertical transmission of HIV-1 in the metropolitan area of belo horizonte, Brazil: 2006\u20132014","volume":"40","author":"Melo","year":"2018","journal-title":"Rev Bras Ginecol Obstet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1590\/0037-8682-0266-2017","article-title":"Treatment adherence in patients living with HIV\/AIDS assisted at a specialized facility in Brazil","volume":"50","author":"Miyada","year":"2017","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"B24","unstructured":"Boletim epidemiol\u00f3gico: HIV\/Aids, 20212021"},{"key":"B25","unstructured":"Nota informativa no 03\/18\/20182018"},{"key":"B26","unstructured":"Nota informativa no 5\/20192019"},{"key":"B27","unstructured":"Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas Para Adultos Vivendo Com HIV\/Aids2013"},{"key":"B28","unstructured":"Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Manejo da Infec\u00e7\u00e3o pelo HIV em Adultos2017"},{"key":"B29","unstructured":"Recomenda\u00e7\u00f5es para Terapia Antirretroviral em Adultos Infectados pelo HIV: 20082008"},{"key":"B30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11904-016-0325-9","article-title":"Community-based interventions to improve and sustain antiretroviral therapy adherence, retention in HIV care and clinical outcomes in low- and middle-income countries for achieving the UNAIDS 90-90-90 targets","volume":"13","author":"Nachega","year":"2016","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5165313","DOI":"10.1155\/2019\/5165313","article-title":"Late onset of antiretroviral therapy in adults living with HIV in an urban area in Brazil: Prevalence and risk factors","volume":"2019","author":"Pacheco","year":"2019","journal-title":"J. Trop. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/PGPM.S15303","article-title":"Individualization of antiretroviral therapy","volume":"5","author":"Pavlos","year":"2011","journal-title":"Pharmgenomics Pers. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/S0140-6736(19)30418-0","article-title":"Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): Final results of a multicentre, prospective, observational study","volume":"393","author":"Rodger","year":"2019","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1080\/14740338.2020.1764531","article-title":"Nothing is perfect: The safety issues of integrase inhibitor regimens","volume":"19","author":"Sc\u00e9vola","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"B35","unstructured":"Boletim Epidemiol\u00f3gico - HIV\/AIDS e outras Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis2018"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e20190193","DOI":"10.1590\/0037-8682-0193-2019","article-title":"Human immunodeficiency virus\/acquired immunodeficiency syndrome epidemic in adolescents from a Brazilian metropolis (1978-2017)","volume":"53","author":"Taquette","year":"2019","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"B37","first-page":"171","article-title":"Cuidado farmac\u00eautico aos pacientes com HIV\/aids","volume-title":"Cuidado Farmac\u00eautico Pacientes com C\u00e2ncer, Hepatite, HIV\/Aids, Dengue e Outras Doen\u00e7as","author":"Toledo","year":"2019"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies","volume":"4","author":"Trickey","year":"2017","journal-title":"Lancet HIV"},{"key":"B39","unstructured":"HIV country profile: 2018 - Brazil2019"},{"key":"B40","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1089\/apc.2017.0081","article-title":"Relationship between single tablet antiretroviral regimen and adherence to antiretroviral and non-antiretroviral medications among veterans\u2019 affairs patients with human immunodeficiency virus","volume":"31","author":"Yager","year":"2017","journal-title":"AIDS Patient Care STDS"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1122018\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T20:28:14Z","timestamp":1680294494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1122018\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,31]]},"references-count":40,"alternative-id":["10.3389\/fphar.2023.1122018"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1122018","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,31]]},"article-number":"1122018"}}